The Correlation Between Ovarian Function and Serum Biomarkers
Key facts
- Who runs it
- Shi Yun
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 35 people, planned
- Started
- 25 Oct 2023
- Planned end
- 11 Nov 2025
- Type of study
- Observational, 3 groups
- Treatments tested
- blood test
- Record updated
- 9 December 2024
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- The selection criteria for healthy individuals are follows; women aged 18-45; Basic FSH<10IU/L, and AMH is within the normal range; Regular menstruation; Agree and sign an informed consent form
- The selection criteria for DOR patients are follows; women aged 18-45; For two consecutive menstrual cycles, 25 ≥ basal FSH ≥ 10IU/L or AMH<1.1ng/ml; Agree and sign an informed consent form
- Selection criteria for POI patients are follows; 18 ≤ females aged <40 years old; Two consecutive menstrual cycles with basal FSH>25IU/L or AMH<1.1ng/ml; Agree and sign an informed consent form
Who cannot take part
- Patients with acquired organic lesions or decreased ovarian function caused by ovarian surgery
- Patients who have undergone artificial cycle therapy with Western medicine or other endocrine treatments within the past three months
- Patients with severe primary diseases and mental disorders such as crdiovascular, cerebrovascular, liver, kidney, and hematopoietic system
- Patients who are allergic to the drugs used in this study or have a history of allergic reactions to traditional Chinese medicine; Those who meet any of the above 5 criteria for DOR and POI will be excluded and not included in this study. The exclusion criteria for healthy subjects are as (1), (3), (4), and (5)
- Patients with congenital gonadal developmental abnormalities or a family history similar to "early menopause"
- Patients during lactation or pregnancy
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to find differences in serum biomarkers between ovarian function and normal individuals.
The 3 groups in the trial
- Diminished Ovarian Reserve Group
women with DOR
Treatment: blood test
- Premature Ovarian Insufficiency Group (POI)
women with premature ovarian insufficiency
Treatment: blood test
- Control Group
women with normal menstruation and levels of sex hormones
Treatment: blood test
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study on the Correlation Between Ovarian Function and Serum Biomarkers
- Criteria questions
- Built from NCT06096766, who can take part
- Record updated
- 9 December 2024